Ironwood Pharmaceuticals Inc Long-term Investment Intensity
Ironwood Pharmaceuticals Inc long-term investment intensity. Ironwood Pharmaceuticals Inc (IRWD) has a Long-term Investment Intensity of 1.3% as of December 2022. Long-term investments of $14.59 Million represent 1.3% of total assets of $1.10 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read Ironwood Pharmaceuticals Inc total liabilities for a breakdown of total debt and financial obligations.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of Ironwood Pharmaceuticals Inc (2015–2022)
Long-term investment intensity of Ironwood Pharmaceuticals Inc from 2015 to 2022. This chart shows how Ironwood Pharmaceuticals Inc's Long-term Investment Intensity has evolved across 8 annual periods from 2015 to 2022. As of December 2022, the intensity stands at 1.3%, reflecting long-term investments of $14.59 Million against total assets of $1.10 Billion USD.
Ironwood Pharmaceuticals Inc Long-term Investment Intensity by Year (2015–2022)
Ironwood Pharmaceuticals Inc long-term investment intensity by year from 2015 to 2022. The table below presents the year-by-year Long-term Investment Intensity for Ironwood Pharmaceuticals Inc from 2015 to 2022, covering 8 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Ironwood Pharmaceuticals Inc balance sheet assets.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2022 | 1.3% | $14.59 Million | $1.10 Billion | ▼ -0.8 pp |
| 2021 | 2.1% | $24.00 Million | $1.13 Billion | ▼ -4.4 pp |
| 2020 | 6.5% | $36.47 Million | $559.24 Million | ▼ -9.4 pp |
| 2019 | 15.9% | $63.96 Million | $402.75 Million | ▲ +3.5 pp |
| 2018 | 12.4% | $41.02 Million | $332.05 Million | ▼ -5.5 pp |
| 2017 | 17.9% | $108.19 Million | $605.67 Million | ▼ -0.8 pp |
| 2016 | 18.7% | $132.52 Million | $709.82 Million | ▲ +4.7 pp |
| 2015 | 14.0% | $86.47 Million | $619.12 Million | — |